Matryoshka-type enteric microparticles for the treatment of tuberculosis

Vanesa Andreu

University of Zaragoza

Vanesa Andreu is a researcher at the University of Zaragoza, Spain. She received her Biochemistry Degree (2004) and her PhD (2010) from the University of Zaragoza. Her current research is oriented to develop new nanostructured drug delivery systems to improve the efficiency, biodisponibility, stability and toxicity of the current therapeutic treatment and to supply them bymore effective and comfortable ways. Also, early-stage preclinical validation of novel therapeutic approaches to demonstrate substantial improvements over non-loaded drug administration in the nanomedicine field.


Introduction The World Health Organization reported in 2015 that the tuberculosis still constitutes a major cause of morbidity and mortality worldwide. The treatment used nowadays presents different limitations such as... [ view full abstract ]


  1. Vanesa Andreu (University of Zaragoza)
  2. Ane Larrea (University of Zaragoza)
  3. Salvador Alfaro (National Polytechnic Institute)
  4. Begoña Gracia (University of Zaragoza)
  5. Gracia Mendoza (University of Zaragoza)
  6. Víctor Sebastián (University of Zaragoza)
  7. José Antonio Ainsa (University of Zaragoza)
  8. Manuel Arruebo (University of Zaragoza)

Topic Areas

Targeted drug delivery and Nanocarriers , Microfluidics in nanomedicine and nanobiology


PS2 » Poster Session & Sponsors Exhibition (13:30 - Thursday, 29th September, Patio 25)

Presentation Files

The presenter has not uploaded any presentation files.